The clinical potential of chemokine receptor antagonists

This publication has 89 references indexed in Scilit:

• Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non‐obese diabetic mice
  European Journal of Immunology, 2004
• Analysis of the involvement of CCR5- 32 and CCR2-V64I variants in the development of endometriosis
  Molecular Human Reproduction, 2004
• Differential expression of b-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts
  Clinical Nephrology, 2004
• Lack of association of CCR2–64I and CCR5-Δ32 with type 1 diabetes and latent autoimmune diabetes in adults
  Human Immunology, 2003
• Pharmacokinetics and Interactions of a Novel Antagonist of Chemokine Receptor 5 (CCR5) with Ritonavir in Rats and Monkeys: Role of CYP3A and P-Glycoprotein
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Frequencies of the G-protein β3 subunit C825T polymorphism and the δ 32 mutation of the chemokine receptor-5 in patients with multiple sclerosis
  Neuroscience Letters, 2002
• Multiple Myeloma
  Hematology-American Society Hematology Education Program, 2002
• Induction of experimental autoimmune encephalomyelitis in C57BL / 6 mice deficient in either the chemokine macrophage inflammatory protein-1α or its CCR5 receptor
  European Journal of Immunology, 2000
• Human Chemokines: An Update
  Annual Review of Immunology, 1997
• Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis.
  Journal of Clinical Investigation, 1994